| Bristol-Myers Squibb Company (BMY) | |||
|---|---|---|---|
| 74.13 -0.4 (-0.54%) | 08-16 16:00 | ||
| Open: | 74.36 | Pre. Close: | 74.53 |
| High: | 75.1 | Low: | 73.845 |
| Volume: | 9,026,976 | Market Cap: | 158,287M |
| Prices Prediction (Update @5:00pm) | ||
|---|---|---|
| If tomorrow: | Open lower | Open higher |
| High: | 75.245 - 75.672 | 75.672 - 76.136 |
| Low: | 72.644 - 73.121 | 73.121 - 73.638 |
| Close: | 73.233 - 74.06 | 74.06 - 74.958 |
| Stock Technical Analysis | |
|---|---|
| Overall: |   |
| Target: | Six months: 88.53 One year: 103.41 |
| Support: | Support1: 73.27 Support2: 71.71 |
| Resistance: | Resistance1: 75.80 Resistance2: 88.53 |
| Pivot: | 73.98  |
| Moving Averages: | MA(5): 74.71 MA(20): 73.75 MA(100): 75.43 MA(250): 67.75 |
| MACD: | MACD(12,26): -0.07 Signal(12,26,9): -0.29 |
| %K %D: | %K(14,3): 75.64 %D(3): 79.68 |
| RSI: | RSI(14): 49.06 |
| 52-Week: | High: 80.59 Low: 53.22 Change(%): 8.2 |
| Average Vol(K): | 3-Month: 11519 10-Days: 7999 |
| Price, MAs and Bollinger Bands |
|---|
| Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ BMY ] has closed below upper band by 46.3%. Bollinger Bands are 18.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
| Stock chart |
|---|
 |
| Financial Analysis | |
|---|---|
| Price to Book Value: | Outperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. | |
| Price to Earnings: | Outperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). | |
| Discounted cash flow: | Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. | |
| Return on Assets: | Neutral |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. | |
| Return on Equity: | Neutral |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. | |
| Debt to Equity: | Outperform |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. | |
| Stock Basics & Statistics | |
|---|---|
| Exchange: New York Stock Exchange | |
| Sector: Healthcare | |
| Industry: Drug Manufacturers—General | |
| Shares Out. (M) | 2140.00 |
| Shares Float (M) | 2130.00 |
| % Held by Insiders | 0.07 |
| % Held by Institutions | 78.67 |
| Shares Short (K) | 27330 |
| Shares Short Prior Month (K) | 34460 |
| Stock Financials | |
|---|---|
| EPS | 3.010 |
| Book Value (p.s.) | 15.270 |
| Profit Margin | 14.04 |
| Operating Margin | 22.42 |
| Return on Assets (ttm) | 6.3 |
| Return on Equity (ttm) | 19.1 |
| Qtrly Rev. Growth | 1.6 |
| Gross Profit (p.s.) | 17.313 |
| Sales Per Share | 22.028 |
| EBITDA (p.s.) | 9.874 |
| Qtrly Earnings Growth | 40.40 |
| Operating Cash Flow (M) | 15400.00 |
| Levered Free Cash Flow (M) | 13860.00 |
| Stock Valuation | |
|---|---|
| PE Ratio | 24.63 |
| PEG Ratio | 2.00 |
| Price to Book value | 4.85 |
| Price to Sales | 3.37 |
| Price to Cash Flow | 10.30 |
| Stock Dividends | |
|---|---|
| Dividend | 0.540 |
| Dividend Yield | 0.01 |
| Dividend Growth | |
